EMAIL THIS PAGE TO A FRIEND

The Journal of clinical investigation

Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus.


PMID 24812665

Abstract

In humans, pruritus (itch) is a common but poorly understood symptom in numerous skin and systemic diseases. Endothelin 1 (ET-1) evokes histamine-independent pruritus in mammals through activation of its cognate G protein-coupled receptor endothelin A receptor (ETAR). Here, we have identified neural endothelin-converting enzyme 1 (ECE-1) as a key regulator of ET-1-induced pruritus and neural signaling of itch. We show here that ETAR, ET-1, and ECE-1 are expressed and colocalize in murine dorsal root ganglia (DRG) neurons and human skin nerves. In murine DRG neurons, ET-1 induced internalization of ETAR within ECE-1-containing endosomes. ECE-1 inhibition slowed ETAR recycling yet prolonged ET-1-induced activation of ERK1/2, but not p38. In a murine itch model, ET-1-induced scratching behavior was substantially augmented by pharmacological ECE-1 inhibition and abrogated by treatment with an ERK1/2 inhibitor. Using iontophoresis, we demonstrated that ET-1 is a potent, partially histamine-independent pruritogen in humans. Immunohistochemical evaluation of skin from prurigo nodularis patients confirmed an upregulation of the ET-1/ETAR/ECE-1/ERK1/2 axis in patients with chronic itch. Together, our data identify the neural peptidase ECE-1 as a negative regulator of itch on sensory nerves by directly regulating ET-1-induced pruritus in humans and mice. Furthermore, these results implicate the ET-1/ECE-1/ERK1/2 pathway as a therapeutic target to treat pruritus in humans.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

90245
2,3,4-Tri-O-acetyl-α-D-arabinopyranosyl isothiocyanate, for chiral derivatization, ≥98.0%
C12H15NO7S
108146
Benzenesulfonamide, ≥98%
C6H7NO2S
M2028
Capsaicin, ≥95%, from Capsicum sp.
C18H27NO3
12084
Capsaicin, analytical standard
C18H27NO3
1091108
Capsaicin, United States Pharmacopeia (USP) Reference Standard
C18H27NO3
Y0000671
Capsaicin, European Pharmacopoeia (EP) Reference Standard
C18H27NO3
360376
Capsaicin, natural
C18H27NO3
21750
Capsaicin, from Capsicum sp., ≥50% (HPLC)
C18H27NO3
PHR1450
Capsaicin, Pharmaceutical Secondary Standard; Certified Reference Material
C18H27NO3
D3630
Diphenhydramine hydrochloride, ≥98% (HPLC)
C17H21NO · HCl
D2600000
Diphenhydramine hydrochloride, European Pharmacopoeia (EP) Reference Standard
C17H21NO · HCl
1218005
Diphenhydramine hydrochloride, United States Pharmacopeia (USP) Reference Standard
C17H21NO · HCl
PHR1015
Diphenhydramine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
C17H21NO · HCl
D7774
Diphenhydramine hydrochloride, analytical standard
C17H21NO · HCl
E7764
Endothelin 1, ≥97% (HPLC), powder
C109H159N25O32S5
59964
Histamine, analytical standard
C5H9N3
H7125
Histamine, ≥97.0%
C5H9N3
53290
Histamine, base, ≥97.0% (NT)
C5H9N3
SRP3209 IL-31 from mouse, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
SRP3091 IL-31 human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
W326305
L-Cysteine, ≥97%, FG
C3H7NO2S
168149
L-Cysteine, 97%
C3H7NO2S
C7352
L-Cysteine, from non-animal source, BioReagent, suitable for cell culture, ≥98%
C3H7NO2S
C5360
L-Cysteine, PharmaGrade, Ajinomoto, from non-animal source, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C3H7NO2S
30089
L-Cysteine, BioUltra, ≥98.5% (RT)
C3H7NO2S
778672
L-Cysteine, produced by Wacker Chemie AG, Burghausen, Germany, ≥98.0%
C3H7NO2S
95437
L-Cysteine, certified reference material, TraceCERT®
C3H7NO2S
S9317
PAR-2 (1-6) amide (mouse, rat) trifluoroacetate salt, ≥97% (HPLC)
C29H56O7N10 · C2HF3O2